Welcome to Hologic Investor Relations

 Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products. The Company’s core business units focus on diagnostics, breast health, GYN surgical, and skeletal health. With a unified suite of technologies and a robust research and development program, Hologic is dedicated to The Science of Sure.

The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol HOLX.

Recent News
Feb 2, 2016

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at these upcoming investor conferences: The LEERINK Partners 5th Annual Global Healthcare Conference in New York, NY on...

Jan 27, 2016

Hologic, Inc. (Nasdaq: HOLX) announced today the Company's financial results for the fiscal first quarter ended December 26, 2015. Revenue of $695.2 million increased 6.5% on a reported basis, and...

Jan 4, 2016

Hologic, Inc. (Nasdaq: HOLX) announced today that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 AB7) issued November 23, 2010, and Wilmington...

Jan 4, 2016

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the first quarter of fiscal 2016 on Wednesday, January 27, 2016, after the market closes....

More ›